MAM
ANAB icon

Meeder Asset Management’s AnaptysBio ANAB Stock Holding History

Meeder Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-240
Closed -$13.3K – 935
2026
Q1 		$13.3K Buy
+240
New +$12.9K ﹤0.01% 641
2020
Q2 		– Sell
-549
Closed -$8K – 2033
2020
Q1 		$8K Buy
549
+157
+40% +$2.38K ﹤0.01% 1600
2019
Q4 		$6K Buy
+392
New +$9.27K ﹤0.01% 1701
2018
Q4 		– Sell
-60
Closed -$5K – 1700
2018
Q3 		$5K Sell
60
-892
-94% -$74K ﹤0.01% 1319
2018
Q2 		$67.6K Buy
952
+828
+668% +$69.5K 0.01% 698
2018
Q1 		$13K Buy
124
+68
+121% +$7.66K ﹤0.01% 993
2017
Q4 		$7K Buy
56
+29
+107% +$2.13K ﹤0.01% 1216
2017
Q3 		$1K Buy
+27
New +$728 ﹤0.01% 1531

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Meeder Asset Management's ANAB Position: Q2 2026 in Review

Meeder Asset Management sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 240 shares — an estimated $13.3K sold.

Meeder Asset Management first reported a position in ANAB in Q3 2017 and held it in 8 quarters. The position peaked at $67.6K in Q2 2018. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Meeder Asset Management reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Meeder Asset Management sold 240 AnaptysBio shares in Q2 2026, an estimated $13.3K.
  • Meeder Asset Management first reported a position in AnaptysBio in Q3 2017 and held it in 8 quarters.
  • Meeder Asset Management's AnaptysBio position peaked at $67.6K in Q2 2018.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.